Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · IEX Real-Time Price · USD
5.22
-0.24 (-4.40%)
At close: May 17, 2024, 4:00 PM
5.20
-0.02 (-0.38%)
After-hours: May 17, 2024, 6:01 PM EDT
RANI Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RANI stock have an average target of 12.2, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 133.72% from the current stock price of 5.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RANI stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +168.20% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +149.04% | May 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $21 → $9 | Strong Buy | Maintains | $21 → $9 | +72.41% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +129.89% | Mar 25, 2024 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +53.26% | Feb 6, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.84
from -1.33
EPS Next Year
-0.67
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 31.7M | 84.1M | 165.0M |
| Avg | n/a | n/a | 19.4M | 35.5M | 89.8M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 332.3% | 365.3% |
| Avg | - | - | - | 82.4% | 153.3% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.61 | -0.48 | -0.45 | 0.02 | 0.76 |
| Avg | -0.84 | -0.67 | -0.48 | -0.20 | 0.17 |
| Low | -0.98 | -0.80 | -0.50 | -0.41 | -0.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.